Perrigo Company plc (NYSE: PRGO), a provider of consumer self-care products, announced on Thursday that its board of directors has approved a quarterly cash dividend of USD0.29 per share, or USD1.16 per share on an annualised basis.
This amount is unchanged from the previous quarterly dividend.
The dividend is payable on 15 December 2026, to shareholders of record as of 27 November 2026.
Abbott declares 411th consecutive quarterly dividend
AbbVie declares quarterly dividend of USD1.73 per share
Alvotech and Lotus agree licensing deal for two biosimilar candidates
Quest Diagnostics declares quarterly dividend of of USD0.86 per share
BSF secures exclusive global commercialisation partnership for ETSYL
Saniona grants AstronauTx worldwide rights to neurological disease programme
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases